Difficulty: Medium
Average Score: 79%
Practice
Which of the following is a long-acting beta-2 agonist commonly used in the management of asthma and COPD?
Correct answer
B
Rationale
The correct answer is B) Salmeterol. Salmeterol is a long-acting beta-2 agonist that is commonly used in the management of asthma and COPD. It works by relaxing the smooth muscles in the airways, leading to bronchodilation and improved breathing over an extended period of time, making it suitable for long-term control and prevention of asthma and COPD symptoms.
Option A) Albuterol is a short-acting beta-2 agonist used for quick relief of asthma symptoms, but it does not provide long-lasting effects like salmeterol.
Option C) Epinephrine is a non-selective beta agonist that has a rapid onset but short duration of action, making it more suitable for acute situations like anaphylaxis rather than long-term management of asthma or COPD.
Option D) Terbutaline is a short-acting beta-2 agonist similar to albuterol and is used for immediate relief of bronchospasm rather than long-term control.
Understanding the differences between short-acting and long-acting beta-2 agonists is crucial in the management of respiratory conditions like asthma and COPD. Long-acting beta-2 agonists play a key role in providing sustained bronchodilation and preventing symptoms over an extended period, contributing to better disease control and improved quality of life for patients.
Option A) Albuterol is a short-acting beta-2 agonist used for quick relief of asthma symptoms, but it does not provide long-lasting effects like salmeterol.
Option C) Epinephrine is a non-selective beta agonist that has a rapid onset but short duration of action, making it more suitable for acute situations like anaphylaxis rather than long-term management of asthma or COPD.
Option D) Terbutaline is a short-acting beta-2 agonist similar to albuterol and is used for immediate relief of bronchospasm rather than long-term control.
Understanding the differences between short-acting and long-acting beta-2 agonists is crucial in the management of respiratory conditions like asthma and COPD. Long-acting beta-2 agonists play a key role in providing sustained bronchodilation and preventing symptoms over an extended period, contributing to better disease control and improved quality of life for patients.